Author： Yap Timothy A Popat Sanjay
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.11, 2013-11, pp. : 1529-1539
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Afatinib for the treatment of advanced non-small-cell lung cancer
By Genova Carlo Rijavec Erika Barletta Giulia Burrafato Giovanni Biello Federica Dal Bello Maria Giovanna Coco Simona Truini Anna Alama Angela Boccardo Francesco Grossi Francesco
Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. :
Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
Current Drug Targets, Vol. 16, Iss. 13, 2015-12 ,pp. :
The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer
By Stinchcombe Thomas E. Socinski Mark A.
Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. :